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In Brief
Malignant conversion of epithelial tumor
cells is incompletely understood. Here,
Vaughan et al. demonstrate that the E3
ligase HUWE1 degrades the RAC
activator TIAM1 following HGF
stimulation, promoting cell junction
disassembly, motility, and invasion in
epithelial cells including lung cancer cells.
This indicates a critical role for HUWE1 in
lung cancer dissemination.
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The E3 ubiquitin ligase HUWE1, deregulated in carci-
noma, has been implicated in tumor formation. Here,
we uncover a role for HUWE1 in cell migration and in-
vasion through degrading the RAC activator TIAM1,
implying an additional function in malignant progres-
sion. In MDCKII cells in response to HGF, HUWE1
catalyzes TIAM1 ubiquitylation and degradation pre-
dominantly at cell-cell adhesions, facilitating junc-
tion disassembly, migration, and invasion. Depleting
HUWE1 or mutating the TIAM1 ubiquitylation site
prevents TIAM1 degradation, antagonizing scat-
tering, and invasion. Moreover, simultaneous deple-
tion of TIAM1 restores migration and invasion in
HUWE1-depleted cells. Significantly, we show that
HUWE1 stimulates human lung cancer cell inva-
sion through regulating TIAM1 stability. Finally, we
demonstrate that HUWE1 and TIAM1 protein levels
are inversely correlated in human lung carcinomas.
Thus, we elucidate a critical role for HUWE1 in regu-
lating epithelial cell-cell adhesion and provide addi-
tional evidence that ubiquitylation contributes to
spatiotemporal control of RAC.
INTRODUCTION
Metastasis, a multistep process beginning with local invasion
and culminating in the colonization of distant organs by cancer
cells, is responsible for more than 90% of all cancer deaths
(Sleeman and Steeg, 2010). Metastasis of carcinoma cells often
commences with the disassembly of junctional complexes
and downregulation of other epithelial traits coupled with the
acquisition of a migratory and invasive mesenchymal phenotype
(so-called epithelial-mesenchymal transition [EMT]). EMT is eli-88 Cell Reports 10, 88–102, January 6, 2015 ª2015 The Authorscited by growth factors such as hepatocyte growth factor
(HGF) secreted by tumor and stromal cells. Acting through its
cognate receptor, c-MET, HGF induces rapid disassembly of ad-
herens junctions through stimulating the ubiquitylation and
associated proteasomal degradation of junctional proteins like
E-CADHERIN (Fujita et al., 2002).
Ubiquitylation—the covalent attachment of ubiquitin to lysine
residues on a target protein—is carried out by three enzymes:
ubiquitin activating enzyme (E1), ubiquitin-conjugase (E2), and
ubiquitin ligase (E3), each comprising a family of proteins. The
HECT, UBA, and WWE domain-containing protein 1 (HUWE1)
is a member of the HECT E3 ubiquitin ligase family whose sub-
strates include key proteins such as p53 and MYC (Adhikary
et al., 2005; Chen et al., 2005), which regulate diverse cellular re-
sponses including proliferation and survival with often opposing
outcomes. Unsurprisingly, HUWE1 has been ascribed both
putative oncoprotein and tumor suppressor functions. Adding
to this controversy, HUWE1 is overexpressed in some cancers
but downregulated in others (Adhikary et al., 2005; Zhao et al.,
2009). Clearly, further investigation is required to resolve the
contribution of HUWE1 to tumorigenesis.
The T lymphoma invasion and metastasis inducing protein 1
(TIAM1) is a guanine nucleotide exchange factor (GEF) that
activates the small GTPase RAC (Michiels et al., 1995). It shows
perturbed expression in various cancers including colon, breast,
and lung (Minard et al., 2005; Stebel et al., 2009; Wang and
Wang, 2012). Previously, we showed that Tiam1 knockout
mice are resistant to H-Ras-induced skin tumors (Malliri et al.,
2002), implying a requirement for TIAM1 in tumor formation
consistent with its roles in cell proliferation and survival (Rygiel
et al., 2008). Intriguingly, the few tumors developing in Tiam1/
mice were more frequently malignant (Malliri et al., 2002),
suggesting that TIAM1 antagonizes malignant progression. Sup-
porting this, TIAM1-RAC activation restored an epithelial-like
phenotype and suppressed invasiveness in RAS-transformed
MDCKII cells (Hordijk et al., 1997). Additionally, TIAM1 depletion
in nontransformed MDCKII cells lead to the disassembly of
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Figure 1. HGF Stimulation Induces TIAM1 Degradation
(A) MDCKII cells were treated with 10 ng/ml HGF for the indicated times, and immunoblotting was performed. pERK was used as readout of HGF activity and
b-ACTIN and total ERK (T-ERK) as loading controls.
(B) Quantification of TIAM1 in (A) from three independent experiments. Mean values ±SE. ****p < 0.0001, ***p < 0.0005, **p < 0.01; ns, not significant (unpaired
t test).
(legend continued on next page)
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their cadherin-based adhesions, acquisition of a flattened
morphology and increased motility (Malliri et al., 2004). Collec-
tively, these findings indicate that TIAM1 promotes cadherin-
based adhesion. Consistent with a role as an invasion suppres-
sor, TIAM1 protein expression is decreased during breast cancer
progression (Stebel et al., 2009). However, the TIAM1-RAC
signaling module can also enhance cell migration and invasion
through promoting lamellipodia and invadopodia (Bourguignon
et al., 2000). Promigratory/proinvasive roles of TIAM1-RAC
manifest when cells are unable to form intercellular adhesions,
e.g., when plated sparsely or on collagen substrates, or in cells
intrinsically lacking E-cadherin, e.g., lymphoma cells (Habets
et al., 1995; Sander et al., 1998). Reflecting its functional diver-
sity, TIAM1 protein has been detected at intercellular junctions,
the Golgi apparatus, the cytosol, and membrane protrusions
(Adams et al., 2010; Mack et al., 2012; Michiels et al., 1995;
Woodcock et al., 2009). We postulate that changes in TIAM1
local concentration brought about by the ubiquitin-proteasome
pathway could impact upon the resultant outcome of TIAM1
stimulation. Potentially, selective degradation of TIAM1 at cell-
cell adhesions triggering their disassembly could preserve the
growth, survival, and dissemination stimulatory properties of
TIAM1-RAC in malignantly transformed cells, while diminishing
their dissemination suppressing properties.
Here, we show that in response to HGF, HUWE1 ubiquitylates
TIAM1 on lysine 595, triggering its proteasomal degradation pre-
dominantly at cell-cell adhesions, thereby enabling disassembly
of cell junctions and induction of cell migration and invasion,
including in lung carcinoma cells. We also show that TIAM1
and HUWE1 protein levels are negatively correlated in early-
stage lung cancer specimens, consistent with this regulatory
mechanism operating in human tumors.
RESULTS
HGF Stimulates Proteasomal Degradation of TIAM1 at
Cell-Cell Junctions
We reasoned that TIAM1 may be downregulated in response to
stimuli that disrupt cell-cell adhesion and induce motility. To test
this hypothesis, we utilized MDCKII cells that in response to HGF
disassemble their cell-cell adhesions and scatter (Uehara and Ki-
tamura, 1992). We detected a transient and profound decrease of
TIAM1protein during the first hour ofHGF treatment, followedbya
secondary less-marked reduction persisting to 12 hr after HGF
treatment (Figures 1A and 1B). Moreover, we observed scattering
of colonies ofMDCKII cellswithin this time frame (Figures S1A and
S1B).We thenmeasured the effect of HGF stimulation on the turn-(C) MDCKII cells were pretreated with 5 mMMG132 for 3 hr where indicated, and
extracted at the indicated times was analyzed by immunoblotting.
(D) Quantification of TIAM1 in (C). Mean values ±SE ***p < 0.0005, **p < 0.01, an
(E and F) MDCKII cells were treated with 10 ng/ml HGF for the indicated times. Cy
immunoblotting. MEK1/2 and CAV1 were used as cytosolic and membrane spec
(G) MDCKII cells expressing Halo-tagged TIAM1 were labeled with 50 nM of fluore
HaloTag blocking agent. Live imaging was performed in the presence or absen
junctions. Scale bar, 10 mm.
(H and I) Fluorescence intensity of Halo-tagged TIAM1 in MDCKII cells wasmeasu
replicates. Mean values ±SE ****p < 0.0001, **p < 0.01, *p < 0.05; ns, not signific
See also Figure S1.
90 Cell Reports 10, 88–102, January 6, 2015 ª2015 The Authorsover of TIAM1 protein by inhibiting new protein synthesis with
cycloheximide. Turnover was greatly increased in cells stimulated
with HGF compared to control cells (Figures 1C and 1D).
Furthermore, downregulation was via protein degradation as we
observed no significant changes in the amount ofmRNA following
HGF treatment (Figure S1C), and the decrease in TIAM1 protein
levels was significantly rescued by treating cells with MG132, a
reversible proteasome inhibitor (Figures 1C and 1D).
To investigate if specific subcellular fractions of TIAM1 were
subject to preferential degradation, we treated MDCKII cells
with HGF and isolated both cytosolic and membrane protein
fractions over a time course of 8 hr. A significant decrease of
endogenous TIAM1 in both membrane and cytosolic fractions
was observed 0.25 hr after HGF treatment (Figures 1E and 1F).
However, as seen for the total cell lysate (Figures 1A and 1B),
the decrease in cytosolic TIAM1 was partially reversed, whereas
the depletion of themembrane fractionwas sustained through all
subsequent time points (Figures 1E and 1F). To further examine
the decrease in TIAM1 seen within the first hour of HGF stimula-
tion, we engineered MDCKII cells to inducibly express Halo-
tagged TIAM1 and analyzed the downregulation of TIAM1-Halo
at cell-cell adhesions as well as in the cytoplasm using a
pulse-chase method described elsewhere (Yamaguchi et al.,
2009).We detected significant TIAM1depletion from cell-cell ad-
hesions but less so from the cytoplasm of HGF-stimulated cells
(Figures 1G–1I). Furthermore, TIAM1 depletion could be rescued
by inhibiting the proteasome (Figures 1G–1I). We therefore
conclude that HGF stimulation induces the preferential depletion
of TIAM1 from cell-cell adhesions.
TIAM1 Is Ubiquitylated in HGF-Stimulated Cells
We next tested whether TIAM1 was modified by ubiquitin (Ub)
during the initiation of HGF-induced cell scattering. Endogenous
TIAM1 was immunoprecipitated under denaturing conditions
and probed for ubiquitin. A significant accumulation of ubiquity-
lated TIAM1 was observed following HGF treatment compared
to untreated control (Figure 2A). K48-Ub chains are considered
the primary signal for proteasomal degradation, and attachment
of four or more Ub molecules to the protein is sufficient to target
proteins to the proteasome (Chau et al., 1989). Using a specific
K48-linked ubiquitin antibody to probe TIAM1 immunoprecipi-
tated under denaturing conditions, we detected a significant
increase of K48-linked TIAM1 after HGF treatment (Figure 2B).
Moreover, this ubiquitin smear was specific to TIAM1, because
downregulating TIAM1 using two different small interfering
RNAs (siRNAs) substantially decreased it (Figure 2C). As further
confirmation, having engineered MDCKII cells to express10 ng/ml HGF and 50 mg/ml cycloheximide (CHX) were added at 0 hr. Protein
d *p < 0.05; ns, not significant (unpaired t test).
tosolic (E) and membrane (F) fractions were prepared and TIAM1 monitored by
ific markers, respectively.
scent TMR ligand, and Halo-tagged TIAM1 was chased through addition of the
ce of HGF for 1 hr. White arrows indicate Halo-tagged TIAM1 at intercellular
red for 30 cell-cell adhesions (H) and cytoplasmic pools (I) from three biological
ant (unpaired t test).
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Figure 2. TIAM1 Is Ubiquitylated following HGF Stimulation
(A) MDCKII cells were pretreated (3 hr) with 5 mMMG132 and treated with 10 ng/ml HGF for the times indicated. Cells were then lysed and endogenous TIAM1
immunoprecipitated (IP) under denaturing conditions and probed for total ubiquitin.
(B) As for (A) but without pretreatment with MG132 and immunoprecipitates were probed using a K48-linkage specific antibody.
(C) MDCKII cells were transfected with a nontargeting siRNA or two siRNAs targeting TIAM1 (#1 and #2). At 96 hr following transfection, cells were treated with
10 ng/ml HGF and protein was extracted at 0.5 hr. TIAM1was immunoprecipitated under denaturing conditions and probed with a K48-linkage specific antibody.
(D) MDCKII cells were pretreated (3 hr) with 5 mMMG132 and with 10 ng/ml HGF for 1 hr and fixed, and the Duolink protocol was performed to monitor the extent
and localization of K48 ubiquitylated TIAM1-HA induced following addition of doxycycline (Plus Dox). White arrows indicate intercellular junctions. Scale bar,
10 mm.
(E) Quantification of Duolink signal in (D) and also in uninduced (Minus Dox) cells. Mean values ±SE of three independent experiments. ****p < 0.0001; ns, not
significant (unpaired t test).
See also Figure S2.HA-tagged TIAM1 following addition of doxycycline, the Duolink
proximity ligation assay (Duolink PLA) revealed a large increase
in TIAM1-HA ubiquitylated with K48-linked Ub in HGF-
stimulated cells compared to untreated cells (Figures 2D, 2E,
and S2). Although TIAM1 ubiquitylated with K48-linked Ub was
distributed throughout the cell, it was enriched at cell-cell adhe-
sions (Figures 2D, 2E, and S2, see white arrows). These data
suggest that TIAM1 is ubiquitylated and degraded via K48-linked
Ub during the early stages of epithelial cell scattering, and that
this degradation occurs more at cell-cell adhesions than in the
cytoplasm.The E3 Ligase HUWE1 Ubiquitylates TIAM1 in
HGF-Stimulated Cells
We previously performed tandem affinity purification (TAP)
of protein complexes from Tiam1/ mouse embryonic fibro-
blasts expressing TAP-tagged TIAM1 (Mack et al., 2012). This
approach also identified the HUWE1 E3 ubiquitin ligase as a
binding partner of TIAM1 (data not shown). This interaction
was validated in vivo using coimmunoprecipitation (co-IP)
both with endogenous proteins in MDCKII cells and exogenous
TIAM1 in HEK293T cells (Figure 3A; Figure S3A, respectively).
Notably, the interaction of TIAM1 and HUWE1 was greatlyCell Reports 10, 88–102, January 6, 2015 ª2015 The Authors 91
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increased in the presence of HGF (Figure 3A). Immunofluores-
cence revealed that, in addition to its previously described
nuclear localization, HUWE1 in MDCKII cells could be clearly
observed at cell-cell junctions, colocalizing with both E-
CADHERIN and TIAM1 (Figure S3B). The Duolink PLA assay
also showed amarked increase in the interaction of endogenous
TIAM1 and endogenous HUWE1 following HGF stimulation,
which again while visualized throughout the cell was significantly
more pronounced along cell-cell adhesions (Figures 3B and 3C).
The documented role of HUWE1 as an E3 ligase indicates
that it could be responsible for regulating the stability of TIAM1
through its ubiquitylation activity. We therefore depleted
HUWE1 using different shRNA and siRNA sequences. This re-
sulted in stabilization of TIAM1 protein (Figures S3C and S3D)
but not mRNA (Figure S3E) and a concomitant reduction of
TIAM1 K48-linked ubiquitylation (Figures 3D and S3F–S3H).
Moreover, the increased turnover of TIAM1 in cells stimulated
with HGF was suppressed by HUWE1 depletion (Figures 3E,
S3I, and S3J). Further, immunofluorescence was performed in
either control or HUWE1-depleted cells before and after HGF
treatment (Figure 3F). In cells treated with a nontargeting control
oligo, TIAM1 was significantly depleted from cell-cell adhesions
but not the cytoplasm following HGF stimulation (Figures 3F and
3G). Significantly, depletion of HUWE1 was able to stabilize
TIAM1 levels at cell-cell adhesions in HGF-treated cells (Figures
3F and 3G). These observations strongly imply that HUWE1 is
largely responsible for the polyubiquitylation and degradation
of TIAM1 at cell-cell adhesions during the induction of epithelial
cell scattering.
HUWE1-Mediated TIAM1 Degradation Controls
HGF-Induced Motility and Invasion of Epithelial Cells
To investigate the potential role of HUWE1 in cell-cell adhesion
and migration and whether this might be through regulating
TIAM1, we depleted HUWE1 and TIAM1 alone and in combina-
tion and assessed the effect on HGF-induced cell motility. Cell
scattering was monitored by phase contrast microscopy (Fig-
ures 4A and S4A) and cells were lysed at 18 hr to confirm
TIAM1 and HUWE1 knockdown by immunoblotting (Figure S4B).
MDCKII cells with depleted HUWE1 scattered significantly less
than cells transfected with the nontargeting control, whereas,Figure 3. TIAM1 Is Ubiquitylated by HUWE1
(A) MDCKII cells were pretreated (3 hr) with 5 mMMG132 and treated with 10 ng/m
TIAM1 was immunoprecipitated, and lysates were probed for HUWE1. Lysates w
(B) MDCKII cells were pretreated with 5 mMMG132 for 3 hr with (Plus HGF) or with
protocol was performed to monitor the extent and localization of the HUWE1 i
junctions. Scale bar, 10 mm.
(C) Quantification of the Duolink signal in (B). Mean values ±SE of three indepen
(D) MDCKII cells were transfected with HUWE1 siRNA #1 or #2 or a nontargeting
0.5 hr where indicated. TIAM1 was immunoprecipitated under denaturing condit
(E) MDCKII cells were transfected with HUWE1 siRNA #1 or a nontargeting siRNA
cells were treated with HGF for the indicated times. Lysates were immunoblotte
control.
(F) MDCKII cells were transfected with HUWE1 siRNA #1 or a nontargeting siRN
indicated and fixed. Cells were stained by immunofluorescence (IF) for E-CADHE
independent experiments. Scale bar, 10 mm.
(G) Quantification of TIAM1 IF levels in (F). Mean values ±SE of three independen
See also Figure S3.in contrast, scattering in cells with depleted TIAM1 was moder-
ately enhanced following HGF treatment (Figures 4A, 4B, and
S4A). To examine if the decreased scattering of HUWE1-
depleted cells was due to an increase in TIAM1 at cell-cell adhe-
sions (as seen in Figures 3F and 3G), we knocked down both
HUWE1 and TIAM1 using two different combinations of siRNA
in MDCKII cells. Interestingly, simultaneous depletion of both
TIAM1 and HUWE1 significantly rescued the scattering of
MDCKII cells (Figures 4A, 4B, and S4A).
Next, we investigated the role of HUWE1-mediated TIAM1
degradation in cell invasion. Seventy-two hours posttransfec-
tion, MDCKII cells in which HUWE1, TIAM1, or a combination
of both were depleted were assayed for short-term (24 hr) and
long-term (120 hr) invasive potential using modified Boyden
chamber assays coated with collagen. Transfected cells were
also seeded in 24-well plates to measure total cell number (in or-
der to normalize cellular invasion to cell number) and 6-well
plates to measure knockdown of TIAM1 and HUWE1 protein
expression (Figure S4C, top) at the end of the experiment. Inva-
sion was quantified by crystal violet staining of cells, which
had invaded through both collagen and insert membrane and
normalized to total cell number. Both short-term (Figures 4C
and 4D) and long-term (Figures S4D and S4E) invasion assays
resulted in similar patterns of invasion. Depletion of HUWE1
alone greatly inhibited the invasion of MDCKII cells stimulated
by HGF. In contrast, the invasion of TIAM1-depleted cells
showed no significant change (Figures 4C, 4D, S4D, and S4E).
Interestingly, the ability of MDCKII cells to invade was signifi-
cantly restored in cells where both HUWE1 and TIAM1 were
downregulated simultaneously (Figures 4C, 4D, S4D, and S4E).
The above findings in MDCKII cells raised the possibility that
aberrant HUWE1 regulation of TIAM1 might occur during tumor-
igenesis, potentially contributing to malignant progression.
HUWE1 is significantly overexpressed in a number of epithelial
tumors including lung carcinoma (Confalonieri et al., 2009). How-
ever, no invasive role had thus far been attributed to HUWE1. To
understand if the above mechanism is relevant in lung carci-
noma, we obtained a number of lung carcinoma cell lines,
including the H1299, H358, H522, and H596 cell lines, which
contain nonfunctional p53 (as depletion of HUWE1 in some set-
tings has been shown to result in stabilization of wild-type p53l HGF as shown, and protein was extracted at the times indicated. Endogenous
ere also subjected to IP with an immunoglobulin G control.
out (Minus HGF) the addition of 10 ng/ml HGF for 1 hr and fixed, and the Duolink
nteraction with TIAM1 (both endogenous). White arrows indicate intercellular
dent experiments. ****p < 0.0001; ns, not significant (unpaired t test).
siRNA (Ctrl). At 96 hr posttransfection, cells were treated with 10 ng/ml HGF for
ions and probed with a K48-linkage specific antibody.
(Ctrl). Cycloheximide (CHX) (50 mg/ml) was added at 96 hr posttransfection, and
d for TIAM1 and HUWE1. In (A), (D), and (E), b-ACTIN was used as a loading
A (Ctrl). At 72 hr posttransfection, cells were stimulated with HGF for 1 hr as
RIN, TIAM1, and DAPI. Panels show representative images from one of three
t experiments. ***p < 0.0005; ns, not significant (unpaired t test).
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and consequent cell death [Kon et al., 2012]). Similar to MDCKII
cells, depletion of HUWE1 in H1299, H358, H522, and H596 cell
lines resulted in increased TIAM1 protein levels (Figure S4C; data
not shown). Further and again comparable to the phenotype we
observed in MDCKII cells, depletion of HUWE1 in H1299, H358,
H522, and H596 cell lines significantly inhibited HGF-induced
invasion. In contrast, TIAM1 depletion did not significantly affect
invasiveness (Figures 4C, 4E–4G, S4D, and S4F; data not
shown). Again, the ability of H1299, H358, H522, and H596
cells to invade was significantly restored in cells where both pro-
teins were downregulated simultaneously (Figures 4C, 4E–4G,
S4D, and S4F; data not shown). These results reveal a role for
HUWE1 in the invasion of lung carcinoma cells through medi-
ating degradation of TIAM1.
TIAM1 Is Ubiquitylated on Lysine Residue 595
Using mass spectrometry, exogenous TIAM1 immunoprecipi-
tated from HEK293T cells was found to be ubiquitylated by
HUWE1 at lysine 595 (K595) (Figure S5A) located in the
MGEMQLSSVTDSKKKKTI peptide in the coiled coil region (Fig-
ure 5A). In vitro ubiquitylation assays revealed a ladder consis-
tent with the attachment of ubiquitin to TIAM1, which was absent
when Ub or ATP was not present (Figure S5B, left) and again
mass spectrometry identified lysine 595 of TIAM1 as a HUWE1
ubiquitylation site (data not shown). p53, a previously identified
substrate of HUWE1, was used as a positive control for the reac-
tion (Figure S5B, right).
To confirm that K595 acts as a bona fide acceptor site for ubiq-
uitin, site-directed mutagenesis was performed to construct a
TIAM1 ubiquitylation mutant. K595 and three lysine residues
that follow were mutated to arginine (Figure 5A) to suppress
lysine acceptor promiscuity, which has been previously docu-
mented (Danielsen et al., 2011). MDCKII cells were engineered
to allow doxycycline (Dox)-induced expression of either wild-
type (WT) or 4x595R mutant TIAM1 (4x595R). Both 4x595R
and WT TIAM1 were clearly observed to colocalize with E-
CADHERIN at cell-cell adhesions (Figures 5B and S5C). Further-
more, we found that following HGF treatment the 4x595Rmutant
TIAM1 was able to both interact with RAC along cell-cell adhe-
sions (Figures 5C and S5D) and activate RAC similarly to WT
TIAM1 (Figure S5E). Thus, 4x595Rmutant TIAM1 functions simi-
larly to WT TIAM1 in these settings. To investigate if the 4x595R
mutant TIAM1 was however defective in ubiquitylation and
degradation, expression of HA-tagged WT and 4x595R mutant
TIAM1 were induced in MDCKII cells that were subsequently
pretreated for 3 hr with MG132 and stimulated with HGF for
30 min. HA-tagged proteins were immunoprecipitated and
probed for K48-linked ubiquitin. HGF treatment promoted K48-(B) Quantification of (A). Percentage of cell scattering was calculated by counting t
colony. At least ten colonies were counted in each of three independent biologic
(C) MDCKII, H1299, H358, and H522 cells were transfected with a nontargeting s
seeded in a modified Boyden chamber coated with collagen I to assay for invasio
crystal violet. Panels show representative images from one of at least three inde
(D–G) Crystal violet from (C) was extracted and absorbance measured at 600 nm
H522 cells by relating optical density to a standard curve of the appropriate cells
values ±SE from three independent experiments. ****p < 0.0001 (unpaired t test)
See also Figure S4.linked ubiquitylation of WT, but not of 4x595R mutant TIAM1
(Figures 5D and S5F). Furthermore, the Duolink PLA assay re-
vealed that, whereas WT TIAM1 and K48-Ub interacted exten-
sively in HGF-stimulated cells and this interaction was enriched
along cell-cell adhesions (Figures 5E, top, 5F, and S5G, top),
4x595R TIAM1 and K48-Ub showed only limited interaction,
which did not appear to be localized to cell-cell adhesions
(Figures 5E, bottom, 5F, and S5G, bottom). Moreover, MDCK
4x595R cells showed significantly increased TIAM1 stability
compared to MDCK WT cells (Figures 5G and S5H). These
data demonstrate that mutation of the K595 ubiquitylation site
on TIAM1 results in a considerable decrease of HUWE1-medi-
ated K48-linked ubiquitylation along cell-cell adhesions and a
resultant increase in overall protein stability.
Ubiquitylation of TIAM1 at Lysine 595 Regulates Cell-
Cell Adhesion Disassembly, Scattering, and Invasion
To further investigate the connection between TIAM1 ubiquityla-
tion and cell-cell adhesion disassembly and migration, we
compared MDCK WT to MDCK 4x595R cells in their ability to
disassemble their cell-cell junctions following HGF stimulation.
In unstimulated MDCKII cells in which expression of either WT
or 4x595R mutant TIAM1 was not induced (minus Dox, minus
HGF), E-CADHERIN, b-CATENIN, and F-ACTIN were localized
at cell-cell contacts forming a characteristic honeycomb pattern
(Figures 6A and 6B, top row). Unstimulated MDCKII cells in
which WT or 4x595R mutant TIAM1 expression had been
induced (plus Dox, minus HGF) exhibited a phenotype similar
to that of control cells (minus Dox, minus HGF) (Figures 6A and
6B, second row). Treatment of noninduced cells with HGF for
1 hr (minus Dox, plus HGF) resulted in disassembly of cell-cell
junctions accompanied by a redistribution of junctional markers
that acquired intracellular localization (Figures 6A and 6B, third
row). HGF-stimulated and induced MDCK WT cells (plus Dox,
plus HGF) behaved similarly to their noninduced counterparts
(minus Dox, plus HGF; Figure 6A, fourth row, see white arrows)
becoming less compact and disassembling their cell-cell junc-
tions. In contrast, disassembly of cell-cell adhesions was mark-
edly delayed in HGF-treated and induced MDCK 4x595R cells
(plus Dox, plus HGF), which retained their junctional organization
as visualized by E-CADHERIN, F-ACTIN, and b-CATENIN stain-
ing (Figure 6B, fourth row, see white arrows).
To extend these observations, we compared the scattering of
MDCKWT and 4x595R cells. Induced MDCKWT cells scattered
following HGF treatment for either 9 or 18 hr (Figures 6C and
S6A), whereas induced 4x595R cells showed a substantial
decrease in scattering at both time points (Figures 6D and
S6B). Protein levels were measured to ensure equivalenthe percentage of cells with less than three cell-cell adhesions remaining in each
al replicates. **p < 0.001 (unpaired t test).
iRNA (Ctrl) or siRNAs targeting TIAM1 or HUWE1 alone or in combination and
n in the presence of 10 ng/ml HGF. After 1 day, invading cells were stained with
pendent experiments. Scale bar, 150 mm.
. Relative invasion was determined for (D) MDCKII (E) H1299, (F) H358, and (G)
and normalizing this to total cell number for each condition and cell line. Mean
.
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TIAM1 expression in doxycycline-induced MDCK WT and
4x595R cells (Figure S6C). Together, these results suggest that
HUWE1-mediated ubiquitylation of TIAM1 on lysine 595 regu-
lates HGF-induced cell-cell adhesion disassembly and scat-
tering in MDCKII cells.
We next investigated whether the reduced scattering of cells
expressing the 4x595R ubiquitylation defective TIAM1 mutant
would lead to impaired cell invasion. Both short- (24 hr; Figures
6E and S6D) and long-term (120 hr; data not shown) invasion as-
sayswere performed as described above. NeitherMDCKWT nor
4x595R cells invaded without HGF (data not shown). Moreover,
noninduced MDCK WT and 4x595R cells readily invaded when
stimulated with HGF (minus Dox; Figures 6E and S6D). Likewise,
MDCK WT clones induced to express WT TIAM1 also invaded
following HGF stimulation (plus Dox; Figures 6E and S6D). How-
ever, MDCK 4x595R cells induced to express the 4x595Rmutant
(plus Dox) invaded significantly less than noninduced 4x595R
(minus Dox) or induced WT cells (plus Dox) stimulated with
HGF (Figures 6E and S6D). Once again, to understand if the
same mechanism is operating in lung carcinoma cells, we per-
formed invasion assays in H1299, H358, and H522 lung cancer
cell lines overexpressing either WT or 4x595R TIAM1. As for
parental cells, no significant invasion of cells expressing either
WT or 4x595R TIAM1 was seen without HGF stimulation (data
not shown). However, both noninduced WT and 4x595R cells
(minus Dox) as well as cell lines induced to express WT TIAM1
(plus Dox) readily invaded with HGF. In contrast, cells induced
to express 4x595R TIAM1 (plus Dox) invaded significantly less
than noninduced 4x595R (minus Dox) or induced WT cells
(plus Dox) stimulated with HGF (Figures 6F–6H and S6E–S6G).
Western blotting was performed to ensure equivalent expression
of WT and 4x595R TIAM1 (Figures S6H–S6J). Based on this
evidence, we conclude that aberrant HUWE1-mediated ubiqui-
tylation of TIAM1 could contribute to the enhanced invasiveness
of lung carcinoma cells.
The results above indicate that HUWE1 plays a role in cell-cell
adhesion, motility, and invasion of epithelial cells in vitro by regu-
lating TIAM1. To investigate this role in vivo, we used a zebrafish
xenograft model. Fluorescently labeled H1299 cells were in-
jected into the pericardial cavity of 2-day-old zebrafish embryos.Figure 5. TIAM1 Is Ubiquitylated at K595
(A) Schematic representation of TIAM1 with the lysine 595 ubiquitylation site hig
(B) MDCKII cells inducibly expressing (Plus Dox) either WT HA-tagged TIAM1 (W
coverslips for 48 hr, fixed, and stained by IF for E-CADHERIN, TIAM1-HA, and DAP
shown. Scale bar, 10 mm.
(C) Quantification of RAC:TIAM1-HA Duolink signal generated by seeding MDCK
TIAM1 (WT #1) or mutant 4x595R TIAM1 (4x595R #1) and stimulating with 10 ng
(D) MDCKII cells inducibly expressing (+ Dox) either WT HA-tagged TIAM1 (W
indicated, with 10 ng/ml HGF, and protein was extracted at 30 min. HA-tagged T
K48-linkage specific antibody.
(E) MDCKII cells inducibly expressing (Plus Dox) either HA-taggedWT TIAM1 or 4x
20 ng/ml HGF for 1 hr and fixed, and the Duolink protocol was performed to monit
intercellular junctions. Scale bar, 10 mm.
(F) Quantification of Duolink signal in (E) and also in unstimulated cells (Minus HG
(G) MDCKII cells noninduced ( Dox) or inducibly expressing (+ Dox) either WT TI
cycloheximide (CHX) and HGF (10 ng/ml) for the indicated times after which prote
TIAM1 from three independent experiments. b-ACTIN was used as a loading con
t test).
See also Figure S5.Seventy-two hours postinjection, tumor cells were observed to
have largely filled the approximately conical shaped cavity.
Several cells were also observed to have disseminated outside
the pericardial cavity, considered to have undergone local inva-
sion (Figure S7A). H1299 cells treated with both a nontargeting
(Ctrl) siRNA and TIAM1 targeting siRNAs also disseminated out
of the pericardial cavity. However, dissemination of H1299
cells in which HUWE1 was depleted was significantly reduced
(Figures 7A and 7B). Remarkably, the ability of H1299 cells
to disseminate was completely restored when HUWE1 and
TIAM1 were downregulated simultaneously (Figures 7A and
7B). To further examine the requirement of TIAM1 ubiquitylation
for invasion in vivo, we injected H1299 cells expressing eitherWT
or 4x595R TIAM1 into the pericardial cavity. All noninduced
(minus Dox) H1299 cells and also H1299 cells expressing WT
TIAM1 (plus Dox) disseminated away from the pericardial region
similarly to parental H1299 cells (Ctrl), whereas cells expressing
the nondegradable 4x595R TIAM1 (plus Dox) showed a strikingly
diminished ability to disseminate (Figures 7C and 7D). Thus,
HUWE1 appears essential for the invasion of lung carcinoma
cells and this is entirely dependent on ubiquitylation of TIAM1.
HUWE1 Expression Is Negatively Correlated with TIAM1
in Squamous Cell Lung Carcinomas
To substantiate the clinical relevance of the above findings in
lung carcinoma, we obtained tissue microarrays containing tu-
mor samples from stage I and stage II squamous cell lung carci-
noma patients. These were stained using immunohistochemistry
(IHC) with specific antibodies recognizing HUWE1, c-MET, and
TIAM1. (c-MET expression has already been shown to correlate
with poor patient outcome in lung cancer [Siegfried et al., 1997].)
In this cohort, 94.3%, 79.8%, and 98.6% of patients were posi-
tive for c-MET, TIAM1, and HUWE1 expression, respectively.
Example images of lung cancer specimens with low and high
HUWE1, TIAM1, and c-MET expression are shown in Figure S7B.
A positive and statistically significant correlation was observed
between HUWE1 and c-MET (Spearman coefficient r = 0.3953,
p = 0.0011, 95% confidence interval [CI] 0.1518–0.5935;
Figure S7C), and, strikingly, a strong inverse correlation was
observed between HUWE1 and TIAM1 expression (Spearmanhlighted in red.
T #1) or mutant HA-tagged 4x595R TIAM1 (4x595R #1) were seeded on glass
I. Representative images fromMDCKWT #1 andMDCK 4x595R #1 clones are
II cells noninduced (Minus Dox) or inducibly expressing (Plus Dox) either WT
/ml HGF for 30 min.
T #1) or mutant HA-tagged 4x595R TIAM1 (4x595R #1) were treated, where
IAM1 was immunoprecipitated under denaturing conditions and probed with a
595Rmutant TIAM1were pretreated for 3 hr with 5 mMMG132 and treatedwith
or the extent and localization of K48 ubiquitylated TIAM1.White arrow indicates
F). Mean values ±SE ****p < 0.0001; ns, not significant (unpaired t test).
AM1 (WT #1) or mutant 4x595R TIAM1 (4x595R #1) were treated with 50 mg/ml
in was extracted. Lysates were immunoblotted for TIAM1-HA. Quantification of
trol in (D) and (G). Mean values ±SE ****p < 0.0001; ns, not significant (unpaired
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coefficient r =0.4812, p < 0.0001, 95%CI0.6582 to0.2539;
Figure 7E) and TIAM1 and c-MET expression (Spearman coeffi-
cient r =0.3497, p = 0.0057, 95%CI0.5582 to0.09977; Fig-
ure S7D). Taken together, these results suggest that the spatio-
temporal regulation of TIAM1 protein expression by the E3 ligase
HUWE1 could be deregulated during lung tumorigenesis.
DISCUSSION
In this study,we have demonstrated a critical role for the E3 ligase
HUWE1 in regulating cell-cell adhesion, cell motility, and invasion.
We show that in epithelial cells, including lung carcinoma cells,
stimulated with HGF, TIAM1—a critical regulator of cadherin-
associatedadhesion— is rapidly targeted for proteasome-depen-
dent degradation via HUWE1-mediated ubiquitylation. Failure to
degrade TIAM1 or depletion of HUWE1 in cells results in delayed
adhesiondisassembly andprevents theHGF-induced stimulation
of migration and invasion. These findings reveal a molecular
mechanism bywhichMET/HGF signaling, whose hyperactivation
is associatedwith invasive growthofmany neoplasms, stimulates
epithelial cell motility and invasion.
Intriguingly, both oncogenic (Adhikary et al., 2005) and tumor
suppressor (Inoue et al., 2013) roles have been attributed to
HUWE1. HUWE1 is overexpressed in cancers of the lung, breast,
colon, prostate, liver, pancreas, and thyroid but downregulated
in stomach and uterine cancer as well as glioblastomas (Adhik-
ary et al., 2005; Confalonieri et al., 2009). The conflicting reports
surrounding HUWE1 function can in part be explained by the na-
ture of its varying substrates, which are involved in a wide variety
of processes including apoptosis (p53, [Adhikary et al., 2005]),
DNA damage response (CDC6 [Hall et al., 2007]), and transcrip-
tional regulation (e.g., p53, c-MYC [Adhikary et al., 2005; Inoue
et al., 2013]). Our findings here suggest that effects of HUWE1
on cell-cell adhesion and invasion via regulating TIAM1 degrada-
tion would promote epithelial tumor progression.
Although both HUWE1 and TIAM1 are expressed in most tis-
sues, it is possible that the mechanism described here for regu-
lating migration is restricted to cells capable of forming cell-cell
adhesions, because it is the pool of TIAM1 expressed at cell-
cell junctions that appears to be preferentially degraded by
HUWE1, allowing cells to move away from each other and
become motile and invasive. It is therefore interesting that
many solid tumors of epithelial origin demonstrate deregulation
of both HUWE1 and TIAM1 protein expression. Indeed, weFigure 6. Ubiquitylation of TIAM1 at Lysine 595 Regulates Cell-Cell Ad
(A and B) MDCKII cells noninduced (Minus Dox) or inducibly expressing (Plus Dox
for 1 hr in the presence (Plus HGF) or absence (Minus HGF) of 20 ng/ml HGF, fi
Representative images from one of two independent MDCKII WT and 4x595R cl
(C and D) MDCKII cells noninduced (Minus Dox) or inducibly expressing (Plus Dox
#2) were incubated for the indicated times with 20 ng/ml HGF. Cell scattering wa
independent MDCKWT (C) andMDCK 4x595R (D) clones by calculating the perce
At least ten colonies were counted in each of three independent biological replic
(E–H) Noninduced (Minus Dox) MDCKII, H1299, H358, and H522 cells or the same
seeded in a modified Boyden chamber to assay for invasion in the presence of 1
violet. Crystal violet was eluted, absorbance was measured at 600 nm, and relati
by relating optical density to a standard curve of the appropriate cell type and t
**p < 0.001, ***p < 0.0005, ****p < 0.0001; ns, not significant (unpaired t test).
See also Figure S6.have shown here that an inverse correlation exists between
TIAM1 and HUWE1 (and TIAM1 and c-MET) in squamous cell
lung carcinoma. We speculate that, in neoplasms characterized
by aberrant HGF/MET signaling, HUWE1 overexpression results
in an increased turnover of TIAM1 at cell-cell adhesions, permit-
ting junction disassembly and stimulating cell motility and inva-
sion—steps vital under certain circumstances for the initiation
of the metastatic cascade. Potentially, pharmacological agents
that disrupt the HUWE1-TIAM1 interaction could be beneficial
in decreasing the HGF/MET-driven metastatic dissemination of
cancer cells.
The TIAM1-RAC signaling module is detected at various sub-
cellular compartments and orchestrates multiple cellular pro-
cesses. Spatiotemporal modulation of TIAM1 and RAC stability
and/or activity is likely to be an important means of regulating
TIAM1-RAC signaling. From our data, we infer that HUWE1-
mediated ubiquitylation is an effective mechanism to achieve
spatiotemporal modulation of TIAM1 protein levels and thereby
regulate motility selectively. In our proposed model (Figure S7E),
TIAM1 primarily at cell-cell adhesions is targeted for proteaso-
mal degradation in cells stimulated with HGF by HUWE1-medi-
ated ubiquitylation, sparing a significant cytoplasmic pool, which
potentially could continue to promote cell growth, survival, and
migration. Alternative mechanisms for controlling TIAM1 stability
have emerged. Previously, we have shown that calpain cleavage
of TIAM1 also regulates TIAM1 stability at adherens junctions but
in the context of oncogenic SRC activation (Woodcock et al.,
2009). Recently, it was shown that TIAM1 can also be targeted
for ubiquitylation by SCF ubiquitin ligase containing b-TRCP
(Magliozzi et al., 2014; Zhu et al., 2014). Intriguingly, we found
that b-TRCP depletion did not impair HGF-induced scattering
of MDCKII cells (data not shown), most likely due to targeting
of a different pool of TIAM1 by b-TRCP compared to HUWE1.
We have also recently shown ubiquitylation of RAC following
HGF treatment of MDCKII cells mediated by the E3 ligase
HACE (Castillo-Lluva et al., 2013). Thus, regulation of TIAM1-
RAC signaling through ubiquitylation and proteasomal degrada-
tion appears pivotal to the rapid response of cells to extracellular
signals.
In conclusion, we show that the E3 ligase HUWE1 is a regu-
lator of cell-cell adhesion, migration, and invasion through the
spatiotemporal modulation of the TIAM1 signaling network. In
epithelial cells with activated c-MET or potentially simply overex-
pressing HUWE1, ubiquitylation of TIAM1 at cell-cell junctionshesion Disassembly, Migration, and Invasion
) either TIAM1WT (WT #1) (A) or TIAM1 4x595R (4x595R #1) (B) were incubated
xed, and costained by IF for F-ACTIN, E-CADHERIN, b-CATENIN, and DAPI.
ones are shown. Scale bar, 10 mm.
) either TIAM1WT (WT #1 andWT #2) or TIAM1 4x595R (4x595R #1 and 4x595R
s monitored by phase contrast microscopy and quantitation performed for two
ntage of cells with less than three cell-cell adhesions remaining in each colony.
ates. *p < 0.05, ***p < 0.0005; ns, not significant (unpaired t test).
cells inducibly expressing (Plus Dox) either TIAM1 WT or TIAM1 4x595R were
0 ng/ml HGF. Cells were left to invade for 1 day, fixed, and stained with crystal
ve invasion was determined for (E) MDCKII, (F) H1299, (G) H358, and (H) H522
hen normalizing this to total cell number for each condition. Mean values ±SE
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Figure 7. HUWE1-Mediated TIAM1 Degradation Controls Lung Carcinoma Cell Invasion In Vivo and HUWE1 and TIAM1 Are Negatively
Correlated in Stage I and II Lung Carcinoma
(A) Green fluorescent H1299 cells were transfected with a nontargeting siRNA (Ctrl) or siRNAs targeting TIAM1 or HUWE1 alone or in combination and injected
into the pericardial cavity of zebrafish embryos. Xenografted cells were imaged at 4 days postinjection (dpi). Right column of images showmerge with bright field.
Scale bar, 100 mm.
(legend continued on next page)
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facilitates both cell-cell adhesion disassembly and invasion, thus
overcoming the dissemination suppressing properties previ-
ously associated with the TIAM1/RAC signaling axis. Because
ubiquitin-coupled degradation of numerous junctional proteins
now appears critical in epithelial dedifferentiation and acquisition
of a motile and invasive phenotype, pharmacological interven-
tions targeting the ubiquitin-proteasome pathway could impact
on carcinoma cell invasion and metastasis.
EXPERIMENTAL PROCEDURES
Constructs, antibodies, cell lines, and siRNA sequences are described in detail
in the Supplemental Experimental Procedures.
Protein Analysis
Cells were lysed in lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1%
[v/v] Triton X-100, 10% [v/v] glycerol, 2 mM EDTA, 25 mM NaF, and 2 mM
NaH2PO4) containing protease and phosphatase inhibitor cocktails (Sigma)
and proteins resolved by SDS-PAGE for western blotting. In protein turnover
experiments, cells were treated with 50 mg/ml CHX for 0–8 hr prior to lysis.
For proteasomal inhibition, cells were incubated for 3 hr with 5 mM MG132.
Biochemical cell fractionation, immunoprecipitation, and GST pull-downs
are described in the Supplemental Experimental Procedures. Rac activity
assays were performed as previously described (Mack et al., 2012).
Ubiquitylation Experiments
In vivo and in vitro detection of protein ubiquitylation were performed as pre-
viously described (Choo and Zhang, 2009) with further details provided in
the Supplemental Experimental Procedures.
Cell Growth
Cell growth was assessed using the Sulforhodamine B assay as previously
described (Vichai and Kirtikara, 2006).
Immunofluorescence Microscopy
Cells were grown on glass coverslips and fixed with 100% ice-cold methanol
or 3.7% formaldehyde. Postfixation, cells were washed with PBS and blocked
with 3% BSA in 0.1% Triton/PBS for 1 hr before antibodies were added.
Halo Pulse-Chase Analysis
Halo pulse-chase analysis was carried out as previously described
(Yamaguchi et al., 2009) with further details provided in the Supplemental
Experimental Procedures.
Duolink PLA
Duolink PLA was performed using the Duolink II Red or Green Starter Kits
(Sigma) following the manufacturer’s instructions and is described in further
detail in Supplemental Experimental Procedures.
Transwell Migration and Invasion Assays
Transwell migration and invasion experiments were performed as previously
described (Marshall, 2011). Modifications are detailed in the Supplemental
Experimental Procedures.(B) Quantitation of invasion depicted in (A). Invasion was normalized to Ctrl. Mea
(Kruskal-Wallis one-way analysis of variance).
(C) Parental green fluorescent H1299 cells (Ctrl), noninduced (Minus Dox), or ind
TIAM1 (4x595R #1 and 4x595R #2) were injected into the pericardial cavity of ze
column of images show merge with bright field. Scale bar, 100 mm.
(D) Quantitation of invasion depicted in (C). In each case, invasion was normalize
experiments. **p < 0.01 (Kruskal-Wallis one-way analysis of variance).
(E) Scatterplot depicting the statistically significant Spearman’s negative correla
See also Figure S7.Xenograft Assays
Xenograft assaywasperformedaspreviouslydescribed (Chapmanetal., 2014).
Further details are provided in the Supplemental Experimental Procedures.
Approval for this procedure was given by The University of Manchester Ethical
Review Board and performed according to UK Home Office Regulations.
Immunohistochemical Analysis
The squamous cell tissue microarray included multiple tumor specimens from
83 patients. Immunopositivity for HUWE1, TIAM1, and c-MET protein expres-
sion in the TMAs was evaluated independently by two investigators (D.N. and
L.V.) as described in Supplemental Experimental Procedures. Ethical approval
for these studies was conferred under the MCRC Biobank Research Tissue
Bank Ethics (07/H1003/161+5) from NRES Committee North West, Greater
Manchester South Ethical.
Statistical Analysis
The specific statistical tests used are indicated in the figure legends alongside
the p values and were carried out using GraphPad Prism version 6.0.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2014.12.012.
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